Beta Drugs Peer Comparison

Beta Drugs Ltd. shows impressive growth metrics and profitability compared to its peers, making it a strong contender in the Pharmaceuticals & Drugs sector. Its low debt levels and high ROE further enhance its attractiveness, positioning it as a potential sector leader alongside a few other outperformers. Conversely, companies like Divi's Laboratories Ltd. exhibit concerning financial metrics, indicating potential risks.

• • Beta Drugs Ltd. has the highest EPS growth and ROE among peers.
• • Cipla Ltd. stands out as a best-value pick due to its low PE and strong profitability.
• • Divi's Laboratories Ltd. is financially weak with negative growth and high valuation ratios.

• • Beta Drugs Ltd.: Highest EPS growth (42.02%) and ROE (26.03%) among peers.
• • Cipla Ltd.: Low PE (23.73) with solid profitability metrics, making it attractive.
• • Mankind Pharma Ltd.: Strong revenue growth (18.12% YoY) coupled with high ROE (23.15%).